Rinath Jeselsohn - Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute

基本信息

Career Trajectory

Bio

Rinath Jeselsohn DFCI, Department of Medicine email: rinath_jeselsohn@dfci.harvard.edu Address: 450 Brookline Ave, Boston MA 02215

Research Interests

Papers共 272 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Imlunestrant a Next-Generation Oral SERD Overcomes ESR1 Mutant Resistance in Estrogen Receptor-Positive Breast Cancer

Shira Sherman, Zachary M Sandusky,Douglas Russo, David Zak,Agostina Nardone, Delia Friel, Francisco Hermida-Prado, Capucine Heraud, Genevra Kuziel, Ana Verma,Giorgio Gaglia,Sheheryar Kabraji, Quang-De Nguyen,Sandro Santagata, Sean W Fanning,Rinath Jeselsohn

JCI insight (2025)

Cited0Views0WOSBibtex

MUC1-C Dependency in Drug Resistant HR+/HER2− Breast Cancer Identifies a New Target for Antibody-Drug Conjugate Treatment

Ayako Nakashoji,Atrayee Bhattacharya, Hiroki Ozawa,Naoki Haratake,Keisuke Shigeta,Atsushi Fushimi,Nami Yamashita,Akira Matsui, Shoko Kure, Tomoe Kameyama, Makoto Takeuchi,Kazumasa Fukuda,Takamichi Yokoe,Aiko Nagayama, Tetsu Hayahsida,Yuko Kitagawa,Renyan Liu, Antonio Giordano,Rinath Jeselsohn, Geoffrey I Shapiro, Donald Kufe

NPJ breast cancerno. 1 (2025): 39-39

Cited0Views0WOSNATUREBibtex

Molecular Characterization of HER2-negative Breast Cancers Reveals a Distinct Patient Subgroup with 17q12 Deletion and Heterozygous Loss of ERBB2

X. Qiu,P. Tarantino, R. Li,A. Grinshpun, H. Gupta,M. E. Hughes, G. Kirkner, L. Scholl, B. E. Johnson, M. Meyerson,A. D. Cherniack, Y. Jiang, N. Zhou,N. U. Lin, H. W. Long,S. M. Tolaney,R. Jeselsohn

ESMO OPEN（2025）

Cited0Views0WOSBibtex

Combined Inhibition of KAT6A/B and Menin Reverses Estrogen Receptor-Driven Gene Expression Programs in Breast Cancer

Sarah Naomi Olsen, Bryn Anderson,Charlie Hatton,Zhengtao Chu, Christopher Simpkins, Yanhe Wen,Wallace Bourgeois, Elena L Haarer, Myles Brown,Rinath Jeselsohn,Alana L Welm,Eneda Toska,Scott A Armstrong

Cell reports Medicinepp.102192-102192, (2025)

Cited0Views0WOSBibtex

Nivolumab Plus Low-Dose Ipilimumab in Hypermutated HER2-negative Metastatic Breast Cancer: a Phase II Trial (NIMBUS)

Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo,Tianyu Li,Sangeetha M Reddy,Leisha A Emens, Thomas M Kuntz, Carolina Alves Costa Silva,Saud H AlDubayan, Hoyin Chu,Beth Overmoyer, Paulina Lange, Molly K DiLullo,Meagan Montesion, Julie Kasparian,Melissa E Hughes, Victoria Attaya, Ameer Basta,Nancy U Lin,Nabihah Tayob,Rinath Jeselsohn, Elizabeth A Mittendorf,Sara M Tolaney

Nature communicationsno. 1 (2025): 4430-4430

Cited0Views0WOSBibtex

A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer

Shom Goel,Bojana Jovanović,Xiangying Chu,Melissa Hughes,Timothy K Erick,Douglas Russo,Molly DiLullo,Eileen Wrabel,Rinath Jeselsohn,Nancy U Lin,Nabihah Tayob,Elizabeth Mittendorf,Stuart Schnitt,Sara M Tolaney

Clinical cancer research an official journal of the American Association for Cancer Researchno. 8 (2025): 1427-1436

Cited0Views0WOSBibtex

Pionera Breast Cancer (BC): Phase III Study of First-Line (1L) Giredestrant Vs. Fulvestrant, Both Combined with a Cyclin-Dependent Kinase 4/6 Inhibitor (cdk4/6i), in Patients (pts) with Estrogen Receptor-Positive (ER+), HER2-locally Advanced/metastatic BC (la/mbc) with Resistance to Prior Adjuvant (adj) Endocrine Therapy (ET)

Kevin Kalinsky,Rinath Jeselsohn,Meritxell Bellet,Peter A. Fasching,Gonzalo Gomez-Abuin,Kyung Hae Jung, Sandrine Lavalle,Vanesa L. Prime Opez-Valverde,Yen-Shen Lu,Richard B. Schwab,Nick Turner,Vanessa Breton,Alberto Zambelli,Fabrice Andre

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Supplementary Table S4 from Estrogen Receptor Mutations As Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer

Jonathan Goldberg,Na Qiao,Jennifer L. Guerriero,Brett Gross,Yagiz Meneksedag,Yoshimi F. Lu,Anne V. Philips,Tasnim Rahman,Funda Meric-Bernstam,Jason Roszik,Ken Chen,Rinath Jeselsohn,Sara M. Tolaney,George E. Peoples,Gheath Alatrash,Elizabeth A. Mittendorf

openalex（2024）

Cited0Views0Bibtex

An Estrogen Receptor Signaling Transcriptional Program Linked to Immune Evasion in Human Hormone Receptor-Positive Breast Cancer

Kenichi Shimada,Daniel E Michaud,Yvonne Xiaoyong Cui, Kelly Zheng,Jonathan Goldberg, Zhenlin Ju,Stuart J Schnitt,Ricardo Pastorello, Lukas D Kania,John Hoffer,Jeremy L Muhlich, Nhan Hyun,Robert Krueger, Alexander Gottlieb, Adam Nelson, Carlos W Wanderley,Gabriella Antonellis,Sandra S McAllister,Sara M Tolaney,Adrienne G Waks,Rinath Jeselsohn,Peter K Sorger,Judith Agudo,Elizabeth A Mittendorf,Jennifer L Guerriero

bioRxiv the preprint server for biology (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn